JZJun-Hua Zheng

Jun-Hua Zheng

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jun-Hua Zheng has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Aspirin use and the risk of prostate cancer: a meta-analysis of 24 epidemiologic studies

    by Tian-Bao Huang, Yang Yan, Zhui-Feng Guo, Xiao-Long Zhang, Huan Liu, Jiang Geng, Xu-Dong Yao, Jun-Hua Zheng

    Several epidemiologic studies were performed to clarify the protective effect of regular aspirin use on prostate cancer risk; however, the results remain controversial. Therefore, we conducted this meta-analysis to assess the association between regular aspirin use and risk of prostate cancer.


  • Coffee consumption and urologic cancer risk: a meta-analysis of cohort studies

    by Tian-Bao Huang, Zhui-Feng Guo, Xiao-Peng Zhang, Huan Liu, Jiang Geng, Xu-Dong Yao, Jun-Hua Zheng

    Controversial results were reported among several epidemiologic studies on the relationship between coffee consumption and urologic cancer risk. We, therefore, conducted this meta-analysis to clarify these associations. Electronic databases including Pubmed, Embase and Cochrane library were searched between January 1966 and August 2013 for eligible studies. Pooled relative risk (RR) and its 95 % confidence interval (CI) were calculated. All P values are two tailed. Thirteen cohorts were eligible for inclusion. As to prostate cancer (PCa), significant reverse association was found among highest versus none/lowest analysis with acceptable heterogeneity (RR 0.86, 95 % CI 0.79–0.95; I 2 25 %, P value for heterogeneity: 0.221). A pooled RR which assessed advanced PCa was 0.73 (with 95 % CI 0.50–1.07), and a slight stronger reverse association was found in fatal PCa. However, a slight insignificant reverse association, basing on 8 studies with 9 outcomes, was found in dose–response analysis (RR 0.98, 95 % CI 0.93–1.03). For kidney and bladder cancer, insignificant associations were found in both highest versus none/lowest analyses and dose–response analyses. Our findings suggest that coffee consumption may reduce the risk of PCa. No associations were found with both bladder and kidney cancer. Further well-designed large-scaled cohort studies are warranted to provide more definitive conclusions.